CD274 and neoplasm: While active immune checkpoint receptors represent a potential mechanism of tumour immune evasion [11] and CTCs might be a surrogate marker of tumour immune evasion [12, 13], an association between CTCs detection and tumoural PD‐L1 expression might exist.